Better Buy: Illumina, Inc. Vs. Intuitive Surgical, Inc.
Todd Campbell, The Motley Fool - Motley Fool - Tue Apr 15, 1:30PM CDT
Health care investors have never been shy about rewarding innovation. Biotech companies continually sport nosebleed valuation based on assumptions that new, game-changing therapies will improve patient outcomes. But biotech isn't the only health...
Financial Readings Announcement Dates -- Research on MGIC Investment, Illumine, Discover Financial Services, and Lexmark Intl.
PR Newswire - Mon Apr 14, 8:00AM CDT
Earningsource.com provides investors with earnings schedule updates throughout the earnings season. With timely information on past earnings performance and earnings projection for their upcoming quarterly release, our aim is to ensure shareholders and traders have an edge on their investment decisions on the following companies: MGIC Investment Corp. (NYSE: MTG), Illumina Inc. (NASDAQ: ILMN), Discover Financial Services (NYSE: DFS) and Lexmark International Inc. (NYSE: LXK). Full earnings notes on MTG, ILMN, DFS and LXK can be downloaded upon signing up at:
Collaborative Agreements, Earnings Release Schedules, Scholarship Programs, and Dividend Declarations - Analyst Notes on Aetna , Illumina , Safeway , Grainger and Fastenal
PR Newswire - Mon Apr 14, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Aetna Inc. (NYSE: AET), Illumina Inc. (NASDAQ: ILMN), Safeway Inc. (NYSE: SWY), W.W. Grainger, Inc. (NYSE: GWW) and Fastenal Company (NASDAQ: FAST). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1070-100free.
Global SNP Genotyping and Analysis Market Forecasts & Opportunities 2013-2019
M2 - Mon Apr 14, 4:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bk2mlx/snp_genotyping) has announced the addition of the "Global SNP Genotyping and Analysis Market Forecasts & Opportunities 2013-2019" report to their offering. The global market is expected to reach USD 9,485.2 million by 2019, up from USD 2,385.2 million in 2012, growing at a CAGR of 21.8% The study elucidates the market dynamics, which are the drivers, restraints and opportunities that a market player will come across in this area. It gives a brief introduction to each topic as it covers the commercial aspects of the market and its technologies along with current trends. The report analyzes four major applications of SNP genotyping in Life Sciences and Healthcare industry which are Pharmaceutical/Pharmacogenomics, Diagnostics, Agricultural Biotechnology and Breeding and Animal Livestock. The market products are internally affected by power of substitution since there are around 8 to 10 different efficient techniques to carry out SNP genotyping such as TaqMan, SNPlex, Microarray, MALDI-TOF etc. With the completion of the Human Genome Project, over 2 million SNP's have been added to global databases which in turn have initiated a series of research and development projects to understand potential of developing diagnostic tests through rapid genotyping techniques. A considerable amount of revenue is spent on research to developing diagnostic products similar to companion diagnostics which would enable to give us a preview of how a genome would unfold as an individual grows older. There is a high intensity of research in food crops such as rice, wheat, oats, corn, maize and other grasses. SNP genotyping in agriculture gained acceptance long before other applications. The GeneChip Rice 44K array offered by Affymetrix is one of the most popular platforms for rice genotyping which identifies variants that impact yield. Fluidigm's SNPtype assays have been utilized by International Rice Research Institute which holds the world's largest ex-situ collection of rice germplasm and plays a very large role in maintaining this repository. Scope of the Report Technology - SNP GeneChips and Microarrays - Taqman Allelic Discrimination - SNP by Pyrosequencing - AB SNPlex - MassARRAY MALDI-TOF - Others Application - Pharmaceuticals and Pharmacogenomics - Diagnostic Research - Agricultural Biotechnology - Breeding and Animal Livestock Key Topics Covered: - Introduction - Executive Summary - Market Overview: Global SNP Genotyping & Analysis Market - Global SNP Genotyping & Analysis Market, by Technologies, 2011 - 2019 (USD Million) - Global SNP Genotyping and Analysis Market, by Applications, 2011 - 2019 (USD Million) - Global SNP Genotyping and Analysis Market, by Geography, 2011 - 2019 (USD Million) - Competitive Landscape - Company Profiles - Affymetrix, Inc - Douglas Scientific LLC - Fluidigm - Illumina, Inc - Life Technologies Corporation - PREMIER Biosoft - Sequenom, Inc - ThermoFisher Scientific Visit http://www.researchandmarkets.com/research/bk...genotyping
3 Health Care Stocks Moving The Sector Upward
at The Street - Fri Apr 11, 12:02PM CDT
TheStreet highlights 3 stocks pushing the health care sector higher today.
Look for Shares of Illumina to Potentially Rebound after Yesterday's 6.93% Sell Off
Comtex SmarTrend(R) - Thu Apr 10, 4:35PM CDT
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $134.00 to a high of $146.56. Yesterday, the shares fell 6.9%, which took the trading range below the 3-day low of $135.71 on volume of 2.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Watch for Illumina to Potentially Rebound After Falling 6.93% Yesterday
Comtex SmarTrend(R) - Thu Apr 10, 4:31PM CDT
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $134.00 to a high of $146.56. Yesterday, the shares fell 6.9%, which took the trading range below the 3-day low of $135.71 on volume of 2.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Analyst Bullish On Medical Research, Equipment Stocks
at Investor's Business Daily - Tue Apr 08, 12:33PM CDT
A new analyst report from Cowen & Co. offers an upbeat assessment of medical research and equipment stocks ahead of first-quarter earnings, thanks to improving end markets. In his report on the Life Sciences and Diagnostic Tools sectors on Tuesday,...
Critical Alerts For Dish Network, Plug Power, Illumina, Time Warner Cable, and Merck Released By InvestorsObserver
PR Newswire - Tue Apr 08, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for DISH, PLUG, ILMN, TWC, and MRK.
Earnings Release Schedules, Product Portfolio Expansion, Initiatives and Stock Price Movements - Analyst Notes on Biogen Idec, Bristol-Myers, Regeneron Pharma, Illumina, West Pharma Services
PR Newswire - Tue Apr 08, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Biogen Idec Inc. (NASDAQ: BIIB), Bristol-Myers Squibb Company (NYSE: BMY), Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), Illumina Inc. (NASDAQ: ILMN), and West Pharmaceutical Services, Inc. (NYSE: WST). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Global Multiplexed Diagnostics Market (Technologies & Applications) 2013 - 2019
M2 - Tue Apr 08, 2:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/m73r7s/multiplexed) has announced the addition of the "Multiplexed Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. This report covers the market analysis of the multiplexed diagnostics technologies namely, very high, high, medium, low density multiplexed assays & next-generation sequencing. This report contains qualitative information about oligonucleotide arrays, phage display, bacterial artificial chromosome arrays, protein arrays, bead-based arrays, antibody arrays, reverse arrays, mass spectrometry, quantitative PCR bead-based and microplate assays and next-generation sequencing. The market is also segmented on the basis of several application areas of multiplexed diagnostics, namely, infectious disease diagnosis, oncology, autoimmune diseases, cardiac conditions, allergies and others (Alzheimer's disease, diabetes, kidney toxicity and HIV). The global multiplexed diagnostics market has phenomenally increased the volume and quality of diagnostic procedures by reducing the turnaround time and analyzing multiple analytes in a single cycle and thereby resulting in rapid adoption of such techniques. The stake holders in this market include market players who provide multiplexed diagnostic assay kits, reagents, solutions and systems. The qualitative details of the market dynamics of the multiplexed diagnostics market such as drivers, restraints and opportunities that influence the current nature and future status of this field are covered under the market overview section of this report. Impact factors such as market attractiveness analysis and Porter's five forces analysis have also been provided in the market overview section of the report in order to give a thorough analysis of the overall competitive scenario in the global multiplexed diagnostics market. The market size and forecast in terms of USD million has been provided in the report for the period 2011 to 2019. This report also includes the overall market growth rate (Compounded Annual Growth Rate) of technologies, applications and geographic market for the period 2013 to 2019, considering 2012 as the base year. The global multiplexed diagnostics market is segmented as follows: Technology - Very high density multiplexed assays - - Oligonucleotide Arrays - - Phage Display - High Density Multiplexed Assays - - Bacterial Artificial Chromosome Arrays - - Protein Arrays - Medium Density Multiplexed Assays - - Bead-based Arrays - - Antibody Arrays - - Reverse Arrays - - Mass Spectroscopy - Low Density Multiplexed Arrays - - Quantitative PCR Bead-based Assays - - Microplate Assays - Next-Generation Sequencing Application - Infectious Disease Diagnosis - Oncology - Autoimmune diseases - Cardiac - Allergies - Others Key Topics Covered: - Introduction - Executive Summary - Multiplexed Diagnostics Market Overview - Global Multiplex Assays Market, by Technology - Global Multiplex Diagnostics Market, By Application - Global Multiplexed Diagnostics Market, by Geography - Recommendations - Company Profiles - Affymetrix, Inc. - Agilent Technologies, Inc. - bioMerieux, Inc. - Bio-Rad Laboratories, Inc. - Illumina, Inc. - F. Hoffman-La Roche, Ltd. - Gen-Probe, Inc. - Life Technologies Corporation - Luminex Corporation - Seegene, Inc. Visit http://www.researchandmarkets.com/research/m7...ultiplexed
Sony: A Surprising New Competitor in Health Care
Leo Sun, The Motley Fool - Motley Fool - Mon Apr 07, 5:30PM CDT
Sony isn't a company most investors normally associate with the health care industry. The Japanese conglomerate is certainly well-known for consumer electronics, but it also has a surprising strategy to expand into health care. Let's take a look at...
Gene Expression Reagent Trends - Global Market Report 2014
M2 - Mon Apr 07, 10:49AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3lbtf8/gene_expression) has announced the addition of the "Gene Expression Reagent Trends" report to their offering. Gene Expression refers to the production of functional products, most commonly proteins, using information saved in a specific gene. Gene expression is a key process undertaken by all life forms, including unicellular as well as multicellular organisms, primarily for generating their macromolecular machinery. The report analyzes and presents an overview of Gene Expression Reagents market worldwide. Supported with 3 market data tables, the report provides a review of global market trends, and various strategic industry activities of major companies witnessed by the industry over the last few years. Key Topics Covered: 1. GENE EXPRESSION REAGENTS - AN OVERVIEW 2. RECENT INDUSTRY ACTIVITY - Sigma-Aldrich Inks Agreement with Olink Bioscience - Synpromics Receives Grant from Technology Strategy Board - Thermo Fisher Scientific to Acquire Life Technologies - Agilent Technologies Inks Licensing Agreement with SRI International - Agilent Technologies Inks Agreement with Roche - ZyGEM Corp Signs Agreement with Quanta BioSciences - Affymetrix Receives US FDA Clearance for Gene Profiling Reagents 3. PRODUCT LAUNCHES/TECHNOLOGICAL INNOVATIONS - Agilent Technologies Launches SureScanDx Microarray Scanner - Illumina Introduces Universal Real-Time PCR Reagent Portfolio - Life Technologies Introduces Compendia Oncomine? Next - Generation Sequencing Power Tools - Mirus Bio Develops TransIT-BrCa Transfection Reagent - Affymetrix Launches Axiom? Genotyping Arrays - Affymetrix Introduces SensationPlus FFPE Reagent Kit - Agilent Technologies Unveils Agilent SurePrint G3 Human Gene Expression v2 Microarray - Agilent Unveils Agilent CytoGenomics 1.0 - Agilent Technologies Introduces GeneSpring GX 11. - Bioinformatics Software - Agilent Technologies Unveils New Exon Analysis Solution 4. MARKET PARTICIPANTS - Affymetrix, Inc. - Agendia, Inc. - Agilent Technologies, Inc. - Applied Biosystems, Inc. - Cepheid - Clontech Laboratories, Inc. - Complete Genomics, Inc. - Cytocell Ltd. - DNA LandMarks, Inc. - DNAVision SA - Dynex Technologies, Inc. - Epicentre? Biotechnologies - Eurofins Medigenomix GmbH - Eurogentec SA - Exiqon A/S - GE Healthcare - Geneworks Pty., Ltd. - Genisphere LLC - Illumina, Inc. - Inqaba Biotechnical Industries Pty., Ltd. - Life Technologies Corporation - Mirus Bio LLC - Ocimum Biosolutions Ltd. - Origene Technologies, Inc. - Quanta Biosciences, Inc. - Roche Diagnostics - Saturn Biotech Ltd. - Sequetech Corporation - Sigma-Aldrich Co. LLC - Thermo Fisher Scientific, Inc. 5. APPENDIX For more information visit http://www.researchandmarkets.com/research/3l...expression
DNA Gene Chip Trends - Global Market Overview 2014
M2 - Mon Apr 07, 10:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c4hnrx/dna_gene_chip) has announced the addition of the "DNA Gene Chip Trends" report to their offering. DNA Gene chips or DNA microarrays are small chips that are engrafted with DNA molecules. The versatile and powerful arrays are commonly used in medicinal and genetics research due to their ability to speed up the process of research. The primary research applications include geneID, comparative genomic hybridization, profiling of gene expression as well as re-sequencing and genotyping in human, plant, prokaryotes and eukaryotes genomes. The report analyzes and presents an overview of DNA & Gene Chip market worldwide. The report in addition provides global market estimates and projections for DNA & Gene Chip (Microarray) in US dollars for years 2012 through 2017. Supported with 6 market data tables the report provides a review of market trends, types and applications DNA microarrays, the current research scenario, and alternative competitive technologies. Key Topics Covered: 1. DNA GENE CHIPS - ACCELERATING MEDICINAL AND GENETIC RESEARCH - DNA Gene Chip - An Introduction - Types of DNA Microarrays - oDNA Microarrays - Spotted cDNA Microarrays - List of Major Applications of Microarrays - Advantages of Microarray Analysis - Top 5 Major Microarray Application Areas with Increasing Demand - DNA Gene Chip Market 2. RESEARCH SCENARIO - Technological Advancements in Biological Analysis - Mitochondrial DNA Microarray for Cancer Detection - Equine Gene Chip - Opens New Possibilities in Preventive Medication 3. COMPETITIVE ALTERNATIVE TECHNOLOGIES - Next Generation Sequencing (NGS) - NGS Technologies Application Areas - Present NGS Platforms - NGS - Key Facts 4. RECENT INDUSTRY ACTIVITY - Thermo Fisher Scientific to Take Over Life Technologies 5. MARKET PARTICIPANTS - Affymetrix, Inc. - Agilent Technologies, Inc. - Applied Microarrays, Inc. - Arrayit Corporation - Biometrix Technology, Inc. - Bioneer Corporation - Bio-Synthesis, Inc. - DNA Chip Research, Inc. - DNAmicroarray, Inc. - Eppendorf AG - Eurofins MWG Operon - Exiqon A/S - Genisphere LLC - Greiner Bio-One GmbH - Illumina, Inc. - LC Sciences - Macrogen, Inc. - Microarrays, Inc. - NGK Insulators Ltd. - Ocimum Biosolutions Ltd. - Oxford Gene Technology - PamGene International BV - PerkinElmer, Inc. - Savyon Diagnostics Ltd. - Scienion AG - Thermo Fisher Scientific, Inc. - Life Technologies Corporation - Toray Industries, Inc. - Toray International UK Ltd. - Toshiba Corporation 6. APPENDIX For more information visit http://www.researchandmarkets.com/research/c4..._gene_chip
Illumina to Announce First Quarter 2014 Financial Results on Tuesday, April 22, 2014
Business Wire - Mon Apr 07, 5:30AM CDT
Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for first quarter 2014 following the close of market on Tuesday, April 22, 2014.
Global Genomics Market Forecasts & Opportunities to 2018 - Products, Consumables & Services
M2 - Mon Apr 07, 3:48AM CDT
Research and Markets (http://www.researchandmarkets.com/research/b5sp23/genomics_market) has announced the addition of the "Global Genomics Market Forecasts & Opportunities to 2018 - Products, Consumables & Services" report to their offering. The global genomics market was valued at $11.11 billion in 2013, and is expected to grow at a CAGR of over 12.0% from 2013 to 2018. The penetration of new markets through the expansion of genomics applications, and advancements in existing technologies plays an important role in attracting new market participants to invest in this market. Next Generation Sequencing (NGS) in personalized medicine and molecular diagnostics is considered as a high growth area for the global genomics market. This new technology provides an affordable and accurate screening solution for genetic mutations. Moreover, the increasing volume of novel genetic tests for personalized medicine and biomarker discovery ensures the continued growth of this market. Tier I and Tier II companies were found to be dominant in the instrument and consumables segments of the genomics market. The genomics market is becoming increasingly consolidated. Among all market players, Roche Diagnostics, Life Technologies, and QIAGEN together accounted for over 47.0% of the revenues earned by the global genomics market in 2013. This concentration of market shares with Tier I market players is expected to challenge market growth. However, technological advancements, and increasing investments are expected to continue to drive the growth of the global genomics market. This report provides comprehensive analysis of market dynamics - drivers, restraints, key market metrics, current market trends, competitive structure, and market revenues and forecasts from 2013 to 2018. It also includes an analysis of mergers and acquisitions in the global genomics market over the last ten years, in addition to technology roadmaps for key technology areas in this market. As a part of the premium insights section, current growth strategies adopted by market participants in the global genomics market have been detailed and analyzed. Scope Products - Instruments - NGS platform - Microarray - RT-PCR Consumables - Genechips - Reagents for DNA Extraction & Purification - Sequencing Services - Sequencing & Microarray Services - Software) Key Topics Covered: - Introduction - Executive Overview - Total Global Genomics Market - Global Genomics Market, By Product Segment - Global Genomics Market, By Technology - Global Genomics Market, By Application - Global Genomics Market, By Geography - Mergers And Acquisitions - Competitive Strategies - Company Profiles - Affymetrix, Inc. - Agilent Technologies, Inc. - Bgi - Bio-Rad Laboratories, Inc. - Cepheid - Ge Healthcare - Illumina, Inc. - Life Technologies, Corp. - Qiagen - Roche Diagnostics For more information visit http://www.researchandmarkets.com/research/b5...ics_market
After Yesterday's Decline of 6.65%, Illumina Offers Investors Better Value
Comtex SmarTrend(R) - Fri Apr 04, 3:56PM CDT
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $135.30 to a high of $151.40. Yesterday, the shares fell 6.6%, which took the trading range below the 3-day low of $146.56 on volume of 3.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Illumina Falls 6.65% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Fri Apr 04, 3:55PM CDT
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $135.30 to a high of $151.40. Yesterday, the shares fell 6.6%, which took the trading range below the 3-day low of $146.56 on volume of 3.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Legal Updates, Stock Price Movements, Launch of New Products, and Trial Results - Analyst Notes on Teva, Lilly, Allergan, Illumina, and Regeneron
PR Newswire - Fri Apr 04, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), Eli Lilly and Co. (NYSE: LLY), Allergan Inc. (NYSE: AGN), Illumina Inc. (NASDAQ: ILMN), and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Upgrade Alert for Illumina (ILMN)
Comtex SmarTrend(R) - Thu Apr 03, 7:05AM CDT
Illumina (NASDAQ:ILMN) was upgraded from Neutral to Outperform at Macquarie today. The stock closed yesterday at $156.57 on volume of 2.0 million shares, below average daily volume of 2.2 million. Illumina has overhead space with shares priced $156.57, or 4.7% below the average consensus analyst price target of $164.33. The stock should hit resistance at its 50-day moving average (MA) of $159.65, as well as support at its 200-day MA of $106.19.